Temsamani Karim Saad 4
4 · Cardlytics, Inc. · Filed Apr 2, 2024
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Temsamani Karim Saad
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-04-01+50,000→ 377,298 total - Sale
Common Stock
2024-04-02$13.69/sh−32,564$445,801→ 344,734 total - Sale
Common Stock
2024-04-01$14.41/sh−154$2,219→ 344,580 total - Exercise/Conversion
Restricted Stock Unit
2024-04-01−50,000→ 0 total→ Common Stock (50,000 underlying)
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
- [F2]Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 1, 2024. The Reporting Person did not sell shares for any other purpose.
- [F3]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.40 to $14.375, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) and (4).
- [F4]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.40 to $14.41, inclusive.
- [F5]This RSU award was originally for 200,000 shares. 25% of the RSU award vested on each of July 1, 2023, October 1, 2023 and January 1, 2024 and April 1, 2024.